Medicortex International AB (publ) (NGM:MEDFIN)

NGM:MEDFIN Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.3	1.42	1.81	2.27	5.45	7.26
Cash & Short-Term Investments	5.3	1.42	1.81	2.27	5.45	7.26
Cash Growth	552.83%	-21.48%	-20.37%	-58.39%	-24.93%	283.52%
Accounts Receivable	0.65	0.7	0.8	1.38	0.3	0.82
Other Receivables	2.54	3.21	6.96	7.68	1.27	0.96
Receivables	3.19	3.9	7.76	9.07	1.57	1.78
Inventory	2.18	2.04	2.24	2.8	3.03	2.39
Prepaid Expenses	0.1	0.08	0.14	0.3	0.4	0.34
Other Current Assets	0	-	-0	0	-	-
Total Current Assets	10.77	7.44	11.95	14.43	10.46	11.78
Property, Plant & Equipment	-	-	7.8	16.51	14.68	0.02
Long-Term Investments	17.85	17.84	15	14.88	5.38	-
Goodwill	-	-	-	12.9	3.34	3.76
Other Intangible Assets	0.16	0.18	0.28	0.37	0.47	-
Long-Term Deferred Charges	2.29	2.36	2.63	2.84	4.01	3.5
Other Long-Term Assets	-	-	-0	0.02	0.02	0.03
Total Assets	31.06	27.83	37.64	61.96	38.36	19.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1	0.72	0.35	1.52	1.84	1.71
Accrued Expenses	1.04	0.88	0.82	1.74	0.85	0.66
Current Portion of Long-Term Debt	-	-	1.09	3.88	1.14	0.72
Current Income Taxes Payable	-	0	0.01	0.34	0.15	0.24
Other Current Liabilities	4.22	0.53	4.39	4.84	1.31	1.49
Total Current Liabilities	6.26	2.13	6.66	12.32	5.3	4.81
Long-Term Debt	-	-	3.4	2.65	5	0.7
Long-Term Deferred Tax Liabilities	-	-	1.09	2.9	2.8	-
Other Long-Term Liabilities	0	-	-0.01	2.1	0.15	0.32
Total Liabilities	6.26	2.13	11.15	19.97	13.25	5.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13.7	13.7	8.82	2.47	1.45	1.06
Retained Earnings	11.1	12	17.67	33.9	21.54	9.64
Comprehensive Income & Other	-0	-	-	-	-	0.12
Total Common Equity	24.8	25.7	26.49	36.36	22.99	10.82
Minority Interest	-	-	0.01	5.63	2.13	2.43
Shareholders' Equity	24.8	25.7	26.5	41.99	25.11	13.25
Total Liabilities & Equity	31.06	27.83	37.64	61.96	38.36	19.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	4.49	6.53	6.14	1.42
Net Cash (Debt)	5.3	1.42	-2.68	-4.26	-0.69	5.85
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	1.93	0.58	-1.22	-34.24	-7.64	89.32
Filing Date Shares Outstanding	3.42	3.42	2.21	0.16	0.09	0.07
Total Common Shares Outstanding	3.42	3.42	2.21	0.16	0.09	0.07
Working Capital	4.5	5.31	5.29	2.12	5.16	6.97
Book Value Per Share	7.24	7.51	12.01	229.94	254.25	159.47
Tangible Book Value	24.64	25.52	26.21	23.09	19.18	7.06
Tangible Book Value Per Share	7.20	7.45	11.89	146.03	212.10	104.08
Buildings	-	-	16.98	16.99	14.74	-
Machinery	-	-	2.52	2.52	3	0.06

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error